A five-day winter school on “Nanotechnology in Advance Drug Delivery” was opened at the National Institute of Pharmaceutical Education and Research (NIPER) in Mohali on Monday. Prof N Sathyamurthy, Director, Indian Institute of Science Education and Research (IISER), Mohali, inaugurated the third winter school.
Sinclair Pharma plc, the international specialty pharma company, announces two separate product development and commercialization deals with BMG Pharma, a privately-owned US-based company. The deals present Sinclair with significant pipeline development opportunities and new product assets.
The high powered committee constituted to set up of an SME Centre at NIPER, Mohali has mooted the idea of developing the proposed SME Centre as an Autonomous Business Centre (ABC) in five years.
The R&D investment deal signed with FirstPoint Biotech shows the attractiveness of the firm’s nano-medical pipeline, particularly given the current economic climate.
India and Russia will now take forward the collaborative science programmes to new areas like ocean research, gas hydrides for energy security and nanotechnology and work for transfer of technology for industry. The research in the emerging areas would help India achieve energy security and use technology for the benefit of the public.
Khandelwal Laboratories use of silver nanotechnology as an antimicrobial was nominated for the year 2008 innovation awards at CPhI.
Cambridge is one of four institutes located outside of Japan which will host a satellite of the 'International Center for Materials Nanoarchitectonics' (MANA). (The University of California, Los Angeles, the Georgia Institute of Technology and CNRS, France will host the other three satellites.) Two branches will be located in Japan at Tsukuba University, Tokyo and Hokkaido University, Sapporo.
Nanobiosym, a leading nanotechnology firm, said that Mr Ratan Tata, Chairman of the multibillion-dollar global conglomerate Tata Group, has joined the firm’s global advisory board.
Edmonton's Research Park in Canada – new center, the first of its kind in Canada – will give entrepreneurs a place to turn ideas into viable, market-ready products.
With Bangalore’s position as emerging leader in nanotechnology and as an international business destination growing manifold over the years, Bangalore the nano hub of India is poised to host the 2nd edition of Bangalore Nano.
Industrial Toxicology Research Centre / Indian Nanoscience Society has organized International Conference on Nanomaterial Toxicology from today till 7th Feburary 2008. in Lucknow, India
Government and private sector should join hands and carry out focused research to make India a significant player in nanotechnology said former President A P J Abdul Kalam at the conference at the National Institute of Technology at Warangal.
Singapore's Institute of Bioengineering and Nanotechnology (IBN) has developed a new miniaturized bioassay that will be faster, cheaper and more efficient for scientists to use
Bilcare Research has launched a product to help check the menace of counterfeit drugs. The product has a label with a unique bar code made out of nanotechnology and fingerprinting.
Starpharma, a key player in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications has signed a collaborative research agreement with Stiefel Laboratories, an independent pharmaceutical company specializing in dermatology, to apply its dendrimer nanotechnology to certain drugs used dermally.
Nanotechnology holds great promise for the development of new treatments and diagnostics. Nanotechnology may provide new drugs that are able to reach specific areas of the body more effectively and at safer doses.
Karnataka government to set up India's first Nano Park in Bangalore and the central government will invest 250 crore.
NanoImaging service centre to provide structural characterization and validation of biopharmaceutica
NanoImaging Services has opened what it claims is a first of its kind fee-for-service imaging business to enable structural characterisation and validation of biological drugs throughout the development pipeline. New Service Offers High-Resolution 3D TEM Imaging of Large Biological Molecules
Pharmaceutical companies are facing expiration of the patent protection on their main profit generators and having relatively fewer new products in the pipeline. Nanomedicine holds the key for future
Public expenditure for nano-technology development in India stays around $ 7 million per annum as against $ 395.5 million of Germany, $ 301.1 million France, $180 million UK, $ 233.5 million South Korea and even $ 102.4 million Taiwan, according to The Associated Chambers of Commerce and Industry of India (ASSOCHAM).